Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 9.36B | 9.38B | 9.21B | 10.58B | 10.48B | 8.47B |
Gross Profit | 2.35B | 2.29B | 2.06B | 2.14B | 2.50B | 1.98B |
EBITDA | 1.88B | 1.80B | 1.81B | 1.73B | 2.42B | 1.54B |
Net Income | 922.00M | 905.00M | 894.00M | 793.00M | 857.00M | 478.00M |
Balance Sheet | ||||||
Total Assets | 14.97B | 15.21B | 14.63B | 14.67B | 15.52B | 16.08B |
Cash, Cash Equivalents and Short-Term Investments | 418.00M | 837.00M | 548.00M | 493.00M | 459.00M | 564.00M |
Total Debt | 5.02B | 5.02B | 4.97B | 5.15B | 5.16B | 5.62B |
Total Liabilities | 9.03B | 9.36B | 9.10B | 9.43B | 9.73B | 9.97B |
Stockholders Equity | 5.87B | 5.78B | 5.46B | 5.15B | 5.70B | 6.02B |
Cash Flow | ||||||
Free Cash Flow | 576.00M | 688.00M | 541.00M | 351.00M | 1.04B | 1.07B |
Operating Cash Flow | 1.14B | 1.29B | 1.37B | 975.00M | 1.62B | 1.46B |
Investing Cash Flow | -486.00M | -534.00M | -432.00M | 392.00M | -29.00M | -394.00M |
Financing Cash Flow | -726.00M | -454.00M | -888.00M | -1.32B | -1.69B | -704.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | $8.80B | 9.71 | 16.16% | 4.36% | 2.78% | 1.50% | |
67 Neutral | $9.22B | 12.91 | 12.52% | ― | -2.64% | 173.69% | |
67 Neutral | $9.93B | 16.59 | 12.17% | 0.47% | -28.74% | 53.25% | |
64 Neutral | $25.91B | 19.34 | 18.47% | 2.38% | -7.67% | -0.58% | |
57 Neutral | $9.76B | 25.60 | 3.71% | 2.76% | -1.27% | 48.34% | |
53 Neutral | $7.64B | ― | -10.58% | 2.49% | -39.34% | -500.52% | |
44 Neutral | C$953.01M | -6.70 | -13.31% | 2.79% | 17.55% | -32.28% |
On June 27, 2025, Eastman Chemical Company announced the appointment of Damon Audia as a director on its Board, to serve until the 2026 Annual Meeting of Stockholders. Mr. Audia will join the Audit, Finance, and Environmental, Safety and Sustainability Committees, receiving compensation aligned with the company’s non-employee directors. This strategic appointment is expected to enhance the company’s governance and oversight capabilities, potentially impacting its operational and sustainability initiatives positively.
The most recent analyst rating on (EMN) stock is a Hold with a $76.00 price target. To see the full list of analyst forecasts on Eastman Chemical stock, see the EMN Stock Forecast page.
In January 2025, Eastman Chemical‘s Steve Crawford transitioned to Executive Vice President, Methanolysis Operations and Worldwide Engineering and Construction Transformation to oversee the Kingsport Methanolysis facility’s startup. With the successful completion of this project, the company decided to eliminate his position as part of succession planning, effective June 2, 2025. Crawford’s responsibilities will be reassigned to other executives, and he will receive severance benefits for his 41 years of service.